AlphAIAlphAI — Financial news for AI agents
SEC EDGAR 6-KAUG 272 min read$NAT

NORDIC AMERICAN TANKERS Ltd (NAT): Financial results for Q2 2026

NORDIC AMERICAN TANKERS Ltd (NAT) furnished an SEC Form 6-K — earnings release. Nordic American Tankers Limited (NYSE: NAT) – Report as per June 30, 2026 – The direction of NAT is unquestionably upwards – rates & values are up Thursday, August 27, 2026 TO SHAREHOLDERS AND INVESTORS, In our report to you a short while ago, we described how Nordic American Tan

Original reporting
SEC EDGAR 6-K
Published Aug 27, 2026, 8:09 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 28, 2026, 6:52 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$NAT
Bullish
high confidence
Mentioned
$NAT
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 6-K
Decision brief

The 30-second read

$NATBullishMed
01

Why it matters

The earnings beat and dividend raise suggest improved cash flow, but geopolitical risk remains.

02

Market read

Earnings release provides fresh data for traders in the shipping sector and may influence related stocks.

03

What to watch

Debt levels of $215.8M and reliance on a few financing partners may limit upside.

Relevance 7/10Novelty 8/10Timing: post‑market Aug 27 2026

Background

Nordic American Tankers Ltd (NYSE:NAT) filed a Form 6‑K reporting its Q2 2026 results, highlighting earnings, dividend, and fleet utilization.

Company-level read

Ticker impact

$NATBullishHigh confidence
Context

Q2 2026 earnings release reporting net profit $68.3M, EPS $0.32 and a $0.27 dividend per share.

Expected impact

Potential short-term price rise on the back of higher earnings and dividend.

Evidence & confidence

Profit up 47% YoY, dividend increase, and higher TCE rates indicate improved operating environment.

Market effects

Sector

Positive earnings may lift other Suezmax tanker operators and related shipping stocks.

Regional

Strengthens sentiment for North American listed maritime transport sector.

Global

Reinforces demand narrative for oil transport amid ongoing geopolitical tensions.

Counterpoint

What could challenge this read

Higher exposure to Hormuz risk could offset earnings gains if tensions flare.

Key entities

  • Company
    Nordic American Tankers Ltd

    NYSE‑listed tanker operator reporting Q2 2026 results.

  • Financial Institution
    Beal Bank

    Financing partner for NAT's fleet.

  • Financial Institution
    Ocean Yield

    Financing partner for NAT's fleet.

Read at source← All news

Related articles

MAY 28
$NATMedAI 9/10

Nordic American Tankers Ltd (NYSE: NAT) - Report as per March 31, 2026 - NAT continues to prosper and raises its dividend. Market conditions for NAT are now the best for several decades.

Nordic American Tankers (NAT) said its Q1 2026 net result was $46.3 million, beating full-year 2025, and it raised its dividend to 22 cents per share, payable June 24, 2026. About 90% of its fleet is booked in Q2 2026 at ~$68,000/day per ship (vs. ~$47,600/day in Q1). NAT also agreed to build two Suezmax tankers for delivery in 2028.

manilatimes.net4 min
SEP 22
$AZOMedAI 8/10

AutoZone Q4 EPS Hits $56.05 as Annual Sales Reach $20.3bn

AutoZone (AZO) reported Q4 2026 EPS of $56.05, up from $48.71 a year earlier, with net sales of $6.6bn, a 5.6% increase. Full-year sales reached $20.3bn, up 7.4%. Gross margin rose to 53.3%, boosted by tariff refunds and LIFO benefits. The company opened 175 new stores, ending the year with 8,031 locations. Shares rose 4.33% post-earnings.

financial-news.co.uk2 min
SEP 22
$AZOHighAI 8/10

Why AutoZone (AZO) Stock Is Trading Up Today

AutoZone (AZO) shares rose 6.1% after reporting Q4 EPS of $56.05, beating estimates. Net sales were $6.6B, missing expectations. Same-store sales grew 1.6%, and gross margin expanded 182 bps to 53.3%. The company's stock has had limited volatility, with today's move being notable. AZO is down 9.9% YTD, trading 30.6% below its 52-week high.

financialcontent.com2 min
SEP 22
$AMGNMedAI 8/10

Amgen Hits Primary Endpoint In Sjögren's Trial, But Approval Filing Awaits Another Trial Data - Amgen (NA

Amgen (AMGN) reported positive results from its Phase 3 OASIZ 301 trial for dazodalibep in treating Sjögren’s disease, meeting the primary endpoint. The study showed statistically significant improvements in disease activity scores. Adverse events were low and similar to placebo. Amgen plans to share full data at a future conference and awaits results from another trial, OASIZ 303, for potential FDA filing. Shares rose 3.54% to $407.08. Analysts expect two positive trials for approval.

benzinga.com4 min